Healthcare -
Biotechnology - NASDAQ - US
$ 3.34
2.77 %
$ 213 M
Market Cap
-2.9
P/E
LRMR - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities LRMR - Larimar Therapeutics, Inc.
33.4 M
LAST VALUE
17.47%
2 YEAR CAGR
46.97%
5 YEAR CAGR
113.46%
10 YEAR CAGR